Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001731122-24-001953
Filing Date
2024-12-06
Accepted
2024-12-06 21:00:23
Documents
1
Period of Report
2024-11-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4327
  Complete submission text file 0001731122-24-001953.txt   5813
Mailing Address 61 MOULTON ST CAMBRIDGE MA 02138
Business Address
MISSLING CHRISTOPHER U (Reporting) CIK: 0001196573 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37606 | Film No.: 241533621

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Issuer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)